Stewardship Over Automation: FDA Redefines AI Accountability in Pharma
In response to a landmark FDA warning, this analysis explores how regulators are shifting from automation to accountable stewardship, redefining governance expectations for AI across...
Read MoreAdvancing CQV: What the Latest ISPE Baseline® Guide Volume 5 Addendum and ASTM E2500-2025 Mean for the Industry
The release of the ISPE Baseline® Guide Volume 5 (Second Edition) QRM Addendum- C&Q Delivery Process and ASTM E2500-2025 marks a significant step forward for...
Read MoreA Commentary on the Draft EMA Annex 15 Changes in the Context of The CAI OR Program
Why the EMA Annex 15 Concept Paper Signals a Shift—and How It Aligns with The CAI Six Pillars of Operational Readiness In Feb 2026 the EMA with...
Read MoreBeyond Batch Testing: What FDA’s Draft Guidance on 21 CFR 211.110 Signals for the Future of Pharmaceutical Manufacturing
How evolving inspection expectations, digital manufacturing, and AI-enabled quality systems are reshaping pharmaceutical control strategies. For many pharmaceutical organizations, the FDA’s draft guidance on Considerations for Complying with 21...
Read MoreFrom Compliance Burden to Strategic Capability
As global regulations continue to evolve, life sciences organizations face increasing pressure to meet stringent compliance expectations without slowing innovation or compromising product quality. The...
Read MoreThe FDA Just Flipped the Switch on Agentic AI – And CAI is Ready!
How digital regulation will reshape quality, compliance and operational expectations across the life sciences ecosystem. Written by: Cassidy Reid & Alice Redmond A Regulator Moving...
Read MoreWINDSOR FRAMEWORK: WHAT IS IT?
The Windsor Framework (WF), which came into effect on January 1, 2025, is a significant agreement between the UK and the EU that replaces the...
Read MoreNavigating Regulatory Complexity in Life Sciences: Turning Compliance into a Strategic Advantage
As global regulations continue to evolve, life sciences companies are facing increasing pressure to meet stringent compliance requirements without slowing down innovation or compromising product...
Read More